Compile Data Set for Download or QSAR
Report error Found 173 of affinity data for UniProtKB/TrEMBL: P28300
TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50526737(CHEMBL4528500 | US10807974, Example 82 | US1099508...)
Affinity DataIC50: 180nMAssay Description:Cell Culture and TransfectionAll cell lines used in this study was purchased from American Type Culture Collection (ATCC). Mycoplasma contamination w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50526721(CHEMBL4444163 | US10807974, Example 111 | US109950...)
Affinity DataIC50: 190nMAssay Description:Cell Culture and TransfectionAll cell lines used in this study was purchased from American Type Culture Collection (ATCC). Mycoplasma contamination w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469007(US10807974, Example 16 | US10995088, Example 16 | ...)
Affinity DataIC50: 300nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50058655(1,1',1'',1'''-[disulfanediylbis(carbonothioylnitri...)
Affinity DataIC50: 320nMAssay Description:Inhibition of recombinant human LOX expressed in HEK293 cells using diaminopentane as substrate preincubated for 30 mins followed by substrate additi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469005(US10807974, Example 9 | US10995088, Example 9 | US...)
Affinity DataIC50: 340nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469011(US10807974, Example 27 | US10995088, Example 27 | ...)
Affinity DataIC50: 400nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469032(US10807974, Example 43 | US10995088, Example 43 | ...)
Affinity DataIC50: 420nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469023(US10807974, Example 39 | US10995088, Example 39 | ...)
Affinity DataIC50: 440nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469008(US10807974, Example 17 | US10995088, Example 17 | ...)
Affinity DataIC50: 450nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469019(US10807974, Example 35 | US10995088, Example 35 | ...)
Affinity DataIC50: 450nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469024(US10807974, Example 40 | US10995088, Example 40 | ...)
Affinity DataIC50: 470nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469004(US10807974, Example 5 | US10995088, Example 5 | US...)
Affinity DataIC50: 480nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469027(US10807974, Example 12 | US10995088, Example 12 | ...)
Affinity DataIC50: 510nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469018(US10807974, Example 34 | US10995088, Example 34 | ...)
Affinity DataIC50: 530nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50232678(CHEBI:27413 | CHEMBL1618272 | US10717734, Compound...)
Affinity DataIC50: 550nMAssay Description:Inhibition of full length recombinant human LOX expressed in HEK cells assessed as reduction in H2O2 production using DAP as substrate preincubated f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2019
Entry Details Article
PubMed
TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50232678(CHEBI:27413 | CHEMBL1618272 | US10717734, Compound...)
Affinity DataIC50: 550nMAssay Description:Inhibition of human LOX expressed in HEK cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details Article
PubMed
TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469010(US10807974, Example 26 | US10995088, Example 26 | ...)
Affinity DataIC50: 550nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469022(US10807974, Example 38 | US10995088, Example 38 | ...)
Affinity DataIC50: 590nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469029(US10807974, Example 42 | US10807974, Example 14 | ...)
Affinity DataIC50: 620nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469025(US10807974, Example 41 | US10995088, Example 41 | ...)
Affinity DataIC50: 690nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469107(US10807974, Example 126 | US10995088, Example 126 ...)
Affinity DataIC50: 700nMAssay Description:Cell Culture and TransfectionAll cell lines used in this study was purchased from American Type Culture Collection (ATCC). Mycoplasma contamination w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469016(US10807974, Example 32 | US10995088, Example 32 | ...)
Affinity DataIC50: 720nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM468996(US10807974, Example 50 | US10995088, Example 50)
Affinity DataIC50: 740nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM468998(US10807974, Example 52 | US10995088, Example 52)
Affinity DataIC50: 760nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469057(US10807974, Example 80 | US10995088, Example 80 | ...)
Affinity DataIC50: 770nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50526737(CHEMBL4528500 | US10807974, Example 82 | US1099508...)
Affinity DataIC50: 770nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469028(US10807974, Example 13 | US10995088, Example 13 | ...)
Affinity DataIC50: 820nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469058(US10807974, Example 81 | US10995088, Example 81 | ...)
Affinity DataIC50: 830nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50501885(CHEMBL4441173 | US10807974, Example 68 | US1099508...)
Affinity DataIC50: 890nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469015(US10807974, Example 31 | US10995088, Example 31 | ...)
Affinity DataIC50: 910nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469061(US10807974, Example 84 | US10995088, Example 84 | ...)
Affinity DataIC50: 910nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469030(US10807974, Example 15 | US10995088, Example 15 | ...)
Affinity DataIC50: 930nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM18351((2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-tr...)
Affinity DataIC50: 1.00E+3nMpH: 4.5 T: 2°CAssay Description:Enzyme activity was determined as the production of fluorescent 4-MU from the substrate. The fluorescence was measured (excitation 362 nm, emission 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2007
Entry Details Article
PubMed
TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM18366((2R,3R,5S,6R)-2,6-bis(hydroxymethyl)piperidine-3,4...)
Affinity DataIC50: 1.00E+3nMpH: 4.5 T: 2°CAssay Description:Enzyme activity was determined as the production of fluorescent 4-MU from the substrate. The fluorescence was measured (excitation 362 nm, emission 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2007
Entry Details Article
PubMed
TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM18353((2R,3R,4R,5S)-2-(hydroxymethyl)-1-methylpiperidine...)
Affinity DataIC50: 1.00E+3nMpH: 4.5 T: 2°CAssay Description:Enzyme activity was determined as the production of fluorescent 4-MU from the substrate. The fluorescence was measured (excitation 362 nm, emission 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2007
Entry Details Article
PubMed
TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50526748(CHEMBL4443558 | US10807974, Example 90 | US1099508...)
Affinity DataIC50: 1.00E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469034(US10807974, Example 45 | US10995088, Example 45 | ...)
Affinity DataIC50: 1.00E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM43362(TETRAMETHYLTHIURAM DISULFIDE | SMR000059023 | MLS0...)
Affinity DataIC50: 1.04E+3nMAssay Description:Inhibition of recombinant human LOX expressed in HEK293 cells using diaminopentane as substrate preincubated for 30 mins followed by substrate additi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469017(US10807974, Example 33 | US10995088, Example 33 | ...)
Affinity DataIC50: 1.10E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469021(US10807974, Example 37 | US10995088, Example 37 | ...)
Affinity DataIC50: 1.10E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469038(US10807974, Example 47 | US10995088, Example 47 | ...)
Affinity DataIC50: 1.10E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50501883(CHEMBL4564517 | US10807974, Example 76 | US1099508...)
Affinity DataIC50: 1.10E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469064(US10807974, Example 53 | US10995088, Example 53 | ...)
Affinity DataIC50: 1.10E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469033(US10807974, Example 44 | US10995088, Example 44 | ...)
Affinity DataIC50: 1.20E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50505638(CHEMBL4457578)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of LOX in human IMR90 cells using putrescine as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469012(US10807974, Example 28 | US10995088, Example 28 | ...)
Affinity DataIC50: 1.30E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469029(US10807974, Example 42 | US10807974, Example 14 | ...)
Affinity DataIC50: 1.40E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469051(US10807974, Example 74 | US10995088, Example 74 | ...)
Affinity DataIC50: 1.40E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM469062(US10807974, Example 85 | US10995088, Example 85 | ...)
Affinity DataIC50: 1.40E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

TargetProtein-lysine 6-oxidase(Human)
The Institute of Cancer Research: Royal Cancer Hospital

US Patent
LigandPNGBDBM50526733(CHEMBL4457629 | US10807974, Example 87 | US1099508...)
Affinity DataIC50: 1.40E+3nMAssay Description:The following reagents were prepared:Reagents500 mM CHES, pH 9 (with NaOH), filtered (MW=207.29)20.7 g in 200 ml in dH2O10% Pluronic F-127 (store at ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 173 total ) | Next | Last >>
Jump to: